Ville Väisänen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ville Väisänen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hans Lilja
Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center , New York, NY
2 shared publications Kim Pettersson
Department of Biotechnology, University of Turku, Turku, Finland, Departments of Clinical Laboratories, Urology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, University Hospital UMAS, Malmö, Sweden, and Department of Surgery, University of Turku, University Central Hospital of Turku, Turku, Finland
2 shared publicationsMartti Nurmi
Department of Biotechnology, University of Turku, Turku, Finland, Departments of Clinical Laboratories, Urology and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, University Hospital UMAS, Malmö, Sweden, and Department of Surgery, University of Turku, University Central Hospital of Turku, Turku, Finland
2 shared publications- Anders Bjartell
Department of Urology, Skåne University Hospital, Malmö, Sweden; Department of Translational Medicine, Medical Faculty, Lund University, Lund, Sweden
1 shared publication Harri Härmä
Department of Urology, Lund University, Malmö University Hospital, SE 205 02 Malmö, Sweden
1 shared publicationKalle Alanen
Department of Pathology, University of Turku and University Central Hospital of Turku, Turku, Finland
1 shared publication
Latest Publications
- 17 October 2006
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 78 (22) , 7809-7815
Intact Free Prostate-Specific Antigen and Free and Total Human Glandular Kallikrein 2. Elimination of Assay Interference by Enzymatic Digestion of Antibodies to F(ab‘)2 Fragments
Various blood constituents can interfere with immunoassays, usually by binding the Fc portion of antibodies. Our previously developed assays for intact free prostate-specific antigen (PSA), free human kallikrein 2 (hK2), and total hK2 frequently yielded falsely high results despite including an excess of scavenger antibodies. We investigated whether this interference could be eliminated by replacing monoclonal capture or tracer antibodies with F(ab‘)2 or recombinant Fab fragments. Female heparin plasma samples (n = 1092), which should have negligible PSA and hK2, and male samples (n = 957) were analyzed to identify samples manifesting interference, which then were used to optimize protocols for the immunoassays. We compared original assays (monoclonal antibodies) versus optimized assays (F(ab‘)2 fragments: denatured mouse IgG added as scavenger) using another set of EDTA plasma (n = 113), heparin plasma (n = 160), and serum samples (n = 171). With the original assays, the frequency of falsely elevated hK2 and intact free PSA was 15 and 13%, respectively. The optimized assays eliminated 70−85% of these falsely elevated results and importantly reduced the magnitude in the remainder. F(ab‘)2 fragmentation was the most important factor in reducing interference. The optimized intact free PSA, free hK2, and total hK2 assays manifested high accuracy close to the lower limit of detection.
- 17 October 2006
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 78 (22) , 7809-7815
Intact Free Prostate-Specific Antigen and Free and Total Human Glandular Kallikrein 2. Elimination of Assay Interference by Enzymatic Digestion of Antibodies to F(ab‘)2 Fragments
Various blood constituents can interfere with immunoassays, usually by binding the Fc portion of antibodies. Our previously developed assays for intact free prostate-specific antigen (PSA), free human kallikrein 2 (hK2), and total hK2 frequently yielded falsely high results despite including an excess of scavenger antibodies. We investigated whether this interference could be eliminated by replacing monoclonal capture or tracer antibodies with F(ab‘)2 or recombinant Fab fragments. Female heparin plasma samples (n = 1092), which should have negligible PSA and hK2, and male samples (n = 957) were analyzed to identify samples manifesting interference, which then were used to optimize protocols for the immunoassays. We compared original assays (monoclonal antibodies) versus optimized assays (F(ab‘)2 fragments: denatured mouse IgG added as scavenger) using another set of EDTA plasma (n = 113), heparin plasma (n = 160), and serum samples (n = 171). With the original assays, the frequency of falsely elevated hK2 and intact free PSA was 15 and 13%, respectively. The optimized assays eliminated 70−85% of these falsely elevated results and importantly reduced the magnitude in the remainder. F(ab‘)2 fragmentation was the most important factor in reducing interference. The optimized intact free PSA, free hK2, and total hK2 assays manifested high accuracy close to the lower limit of detection.
- 1 November 2000
- Published by Wiley in Luminescence
- Vol. 15 (6) , 389-397
Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies
- 1 November 2000
- Published by Wiley in Luminescence
- Vol. 15 (6) , 389-397
Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies